HCM
ASBPW

Highbridge Capital Management’s Aspire Biopharma Warrant ASBPW Stock Holding History

Highbridge Capital Management’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 413
2026
Q1 		– Hold
0
– – – 358
2025
Q4 		– Hold
0
– – – 278
2025
Q3 		– Hold
0
– – – 268
2025
Q2 		– Hold
0
– – – 233
2025
Q1 		– Hold
0
– – – 152
2024
Q4 		– Hold
0
– – – 216
2024
Q3 		– Hold
0
– – – 216
2024
Q2 		– Hold
0
– – – 239
2024
Q1 		– Hold
0
– – – 271
2023
Q4 		– Hold
0
– – – 221
2023
Q3 		– Hold
0
– – – 333
2023
Q2 		– Hold
0
– – – 409
2023
Q1 		– Hold
0
– – – 444
2022
Q4 		– Hold
0
– – – 490
2022
Q3 		– Hold
0
– – – 451
2022
Q2 		– Hold
0
– – – 478

Other funds holding ASBPW

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return